Eifrig's new Prosperity Investor pitches Seven "Forever" stocks and three "1,000% Winner" speculations -- and the Thinkolator has definite answers for six of those ten below, plus a few guesses at the others...
27 Comments Read MoreArticles
Eifrig’s “Shock to Retirement” Pitch — Who are the winners of his “Health Care Singularity?”
Big Bucks from Big Prostates?
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] Readers not familiar with Stock Gumshoe usually arrive wondering if the salivation provoked by stock promotional writers for certain companies is justified. […]
560 Comments Read MoreCatching up on some favorites and a couple add-on personal buys for the Friday File
“This Stock is Going Up, Big Time” — Porter Stansberry
“A Market Insider and Lifelong Friend Hands Me the Best Opportunity of 2009 “‘I can’t imagine a better stock to buy.'” That’s how the newest ad launches for Porter Stansberry’s Inside Strategist, a newsletter that has churned through at least two editors in the last few years, but which is now apparently run by Porter […]
30 Comments Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
$BSX Boston Scientific to buy Symetis for $435 mln. Valve implantation. Competition with Metronics and Edwards....
Trade notice:Exit Boston Scientific $BSXRationale: Extended epoch of growth beginning in 2014 appears to have co...
One more sign that ardor for dealmaking is returning: Boston Scientific snaps up tiny Georgian endoscopy tech company En...
Author: ed226914 Comment Link: http://www.stockgumshoe.com/reviews/alternative-energy-speculator/nick-hodges-the-one-an...
NMKEF, will be the first to produce battery grade LI on a commercial scale. bought it at different times from .30 to $1...
I bought NMKEF at .30, might want to take a look at share price now, They go into full commercial production in H2, 2018...
This is a bit of an aside, but I've been thinking of putting together a tracking index of the biotechs followed here. W...
Fine coverage from Tracy Staton at Fierce of Salix's woes:http://www.fiercepharma.com/marketing/headline?utm_medium=...
TRXC Board Email addresses Paul Laviolette Chairman of the Board EMAIL paul.laviolette@svlsa.comLaViolette brings n...
Sandra, if you really suffer from chronic back pain, why not consider spinal cord stimulation with an implantable neuros...
Porter S had predicted the imminent demise of G about two years ago and had promoted Boston Scientific as a great BUY! ...
One biotech company we semi-follow here has had the most upgrades of any in the last 90 days: Boston Scientific ($BSX). ...
Good news for Celladon? From the little I just read online about Scott Garrett it looks like he has a lot of experience...
David B: To be fair, my mind is not closed about Medifocus. My main "issue" there is that Boston Scientific (I have shar...
When I first heard about the MedTronic Covidien tie up I was thinking this is like a frog marrying an apple. I was conf...
Paul ,try BSX Boston scientific. I have seen that teased before but I don't know of ant new developments.....
I am quite confused by the Prolieve situation where it concerns Medifocus. Something doesn't add up. I have been aware o...
I've been a subscriber for almost a year. Earlier this year Porter recommended BSX (Boston Scientific) and stated that h...
Just remember one thing. Porter Stansberry is the same guy that told everyone that would listen to buy shares in Boston...
The thing that really jumps out at me is the fact that this company only has 22 million shares of stock outstanding. Wh...
Yesterday (the 19th), you guessed that the latest Stansberry "Got to Act Before Today (the 20th)"-- because of an allege...
It's Boston Scientific (BSX) -- wrote about them a few months ago when Porter started this campaign....
I took the following from an RTT News story about Johnson and Johnson that was posted on-line on October 13, 2009: "Amon...